Physicochemical characterization of stealth liposomes encapsulating an organophosphate hydrolyzing enzyme

Journal of Liposome Research

Volumn 19, Issue 2, 2009, Pages 163-168

  Budai, Marianna ^a,b   Chapela, Patricia ^b   Grf, Pl ^a   Zimmer, Andreas ^c   Wales, Melinda E ^d   Wild, James R ^d   Klebovich, Imre ^a   Petrikovics, Ilona ^b   Szilasi, Mria ^e  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SAM HOUSTON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

^d TEXAS A AND M UNIVERSITY   (United States)

^e UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Drug delivery; Dynamic light scattering; Electron paramagnetic resonance spectroscopy; Enzyme containing stealth liposome; Organophosphorus antagonism

Indexed keywords

HYDROLASE; LIPOSOME; ORGANOPHOSPHATE; ORGANOPHOSPHORUS COMPOUND; PARAOXON; ANTIDOTE; PHOSPHOTRIESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; ENCAPSULATION; IN VITRO STUDY; IN VIVO STUDY; INTOXICATION; LIGHT SCATTERING; MEMBRANE; NONHUMAN; OSMOLARITY; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THERAPY EFFECT; VISCOSITY; CHEMISTRY; HYDROLYSIS;

ANTIDOTES; DRUG DELIVERY SYSTEMS; HYDROLYSIS; LIPOSOMES; ORGANOPHOSPHATES; PARAOXON; PHOSPHORIC TRIESTER HYDROLASES; VISCOSITY;

EID: 70350599650     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/17482940902724044     Document Type: Article

References (19)

1. Ashani Y, Rothshild N, Segall Y, Levanon D, Raveh L. Prophylaxis against organophosphate poisoning by an enzyme hydrolysing organophosphorus compound in mice. Life Sci. 1991;49:367-374.
2. Broomfield CA. A purified recombinant phosphotriesterase protects mice against soman. Physiol Toxicol. 1992;70:65-66.
3. Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A. 1988;85:6949-6953.
4. Gregoriadis G, Florence AT. Liposomes in drug delivery: clinical, diagnostic, and ophthalmic potential. Drugs. 1993;45:15-28.
5. Marsh D. Electron spin resonance: spin labels. In: Grell E, (Ed.), Molecular Biology Biochemistry and Biophysics, Membrane Spectroscopy 1981; (pp 51-142). Berlin, Germany: Springer.
6. Pei L, Petrikovics I, Way JL. Antagonism of the lethal effect of paraoxon by carrier erythrocytes containing organophosphorous acid anhydrase. Fundam Appl Toxicol. 1994;28:209-214.
7. Petrikovics I, Hong K, Omburo G, Hu QZ, Pei L, McGuinn WD, Sylvester D, Tamulinas C, Papahadjopoulos D, Jaszberenyi JC, Way JL. Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes. Toxicol Appl Pharmacol. 1999;156:56-63.
8. Petrikovics I, McGuinn WD, Sylvester D, Yuzapavik P, Jiang J, Way JL, Papahadjopoulos D, Hong K, Jin R, Cheng TC, Defrank JJ. In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism. Drug Deliv. 2000;7:83-89.
9. Rosenson RS, McCormick A, Uretz EF. Distribution of blood viscosity values and biochemical correlates in healthy adults. Clin Chem. 1996;42:1189-1195.
10. Senior J, Delgado D, Fisher D, Tilcock D, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethyleneglycol)-coated vesicles. Biochem Biophys Acta. 1991;1062:77-82.
11. Sogorb MA, Díaz-Alejo N, Escudero MA, Vilanova E. Phosphotriesterase activity identified in purified serum albumins. Arch Toxicol. 1998;72:219-226.
12. Szabó ZS, Budai M, Blaskó K, Gróf P. Molecular dynamics of the cyclic lipodepsipeptides' action on model membranes: effects of syringopeptin22A, syringomycin E, and syringotoxin studied by EPR technique. BBA Biomembr. 2004;1660:118-130.
13. Takeuchi H, Kojima H, Yamamoto H, Kawashima Y. Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. J Contr Rel. 2001;75:83-91.
14. Torchilin VP. Immobilized enzymes as drugs. Adv Drug Del Rew. 1988;1:270.
15. Torchilin VP, Papisov ML. Why do polyethylene glycol coated liposomes circulate so long? J Liposome Res. 1994;4:725-739.
16. Torchilin VP, Trubetskoy VS, Milshteyn AM, Canillo J, Wolf GL, Papisov MI, Bogdanov A, Narula J, Khaw BA, Omelyanenko VG. Targeted delivery of diagnostic agents by surface- modified liposomes. J Contr Rel. 1994;28:45-58.
17. Walde P, Ichikawa S. Enzymes inside lipid vesicles: preparation, reactivity, and applications. Biomol Eng. 2001;18:143-177.
18. Way JL. Spectrophotometric determination of paraoxonase within mouse carrier erythrocytes. Biochem Appl Biotechnol. 1994;20:34-41.
19. Zhao L, Feng SS, Kocherginsky N, Kostetski I. DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane. Int J Pharm. 2007;338:258-266.